Activity of CDK4/6 Inhibitors and Parameters Affecting Survival in Elderly Patients in Age-Subgroups: Turkish Oncology Group (TOG) Retrospective Study
Seda Kahraman,Mutlu Hizal,Burcin Cakan Demirel, Deniz Can Guven,Ozge Gumusay,Basak Oyan Uluc,Ertugrul Bayram,Burcu Gulbagci,Alper Yasar,Sena Ece Davarci,Eda Eylemer Mocan,Omer Acar,Deniz Isik,Esra Aydin,Yusuf Karakas,Melike Ozcelik,Murat Keser,Sadi Kerem Okutur,Onder Eren,Serkan Menekse,Dincer Aydin,Funda Yilmaz, Ozlem Dogan, Gulhan Ozkanli, Hakan Yucel,Veli Sunar,Musa Baris Aykan,Ozlem Ozdemir,Berna Bozkurt Duman,Merve Keskinkilic,Teoman Sakalar,Ali Inal, Muge Karaoglanoglu,Asude Aksoy,Muhammed Muhiddin Er,Nazim Serdar Turhal,Nurhan Onal Kalkan,Mehmet Ali Nahit Sendur BMC Cancer（2024）
Key words
CDK 4/6 inhibitors,Metastatic breast cancer,Geriatric population
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper